Close

News

Bristol Myers Squibb Enters Agreement to Acquire Forbius, Adding Lead TGF-beta Asset to Portfolio

Bristol Myers Squibb and Forbius, a privately held, clinical-stage protein engineering company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases, announced that they have entered into a definitive agreement under which Bristol Myers Squibb...

Quanticate Announces new Partnership with Antev Ltd

Quanticate is pleased to partner with Antev Limited on a Phase II, Open-Label, Multicentre Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix Trifluoroacetate, a GnRH antagonist, in Participants with Advanced Prostate Cancer. Prostate cancer is one of the...

UAEs Mubadala invests in US pharma business

Abu Dhabi’s sovereign wealth fund, Mubadala, and New York-based private equity group Kohlberg will take a majority stake in the pharmaceutical company PCI Pharma Services, UAE state news agency WAM said. Kohlberg is set to take a majority stake in...

Frontida BioPharma Completes Facility Expansion

Frontida BioPharm, Inc. announced the completion of a facility expansion to their oral solid dose manufacturing operations with the commissioning of a Highly Potent Compound Contract Manufacturing Suite. This addition features 1000 sq. ft of readily available, hazard-certified production...

Symbiosis confirms commitment to growth strategy with key appointment

Symbiosis Pharmaceutical Services (Symbiosis), a fast-growing contract manufacturing organisation (CMO) specialising in sterile manufacture of vaccines, pharmaceuticals and biopharmaceuticals, and headquartered in Stirling, UK, has appointed Mr. John McCormick as chief operating officer (COO) and executive member of its...

Europital forecast 30% CAGR from UK biotech for three years

Europital – the global provider of medical management services for clinical research and drug development – announces it is opening a UK site to further expand its services to the UK biotech industry. The company is already working with...

Informa Markets in India all set to host the 9th edition of InnoPack Pharma Confex, virtually this year

CPhI Conferences India, a division of Informa Markets in India, which hosts a number of successful pharmaceutical conferences, has announced the 9th Annual InnoPack Pharma Confex slated for 3rd and 4th September 2020, this year in a virtual format....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read